A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Crossover, Placebo-Controlled Pilot Study

New clinical reports have recently been published on tofisopam—an anxiolytic drug currently registered as a benzodiazepine—after a long break in this research area. Neurobiological studies concerning its properties, which differ from those of benzodiazepines, are underway. The analyses presented in...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkki: Andrzej Kokoszka
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: MDPI AG 2024-01-01
Ráidu:Pharmaceuticals
Fáttát:
Liŋkkat:https://www.mdpi.com/1424-8247/17/1/140